|
humans |
18 |
|
middle aged |
17 |
|
female |
15 |
|
male |
14 |
|
adult |
8 |
|
treatment outcome |
7 |
|
age factors |
6 |
|
antiplatelet agents |
6 |
|
aspirin - administration & dosage - adverse effects |
6 |
|
follow-up studies |
6 |
|
intracranial hemorrhages - drug therapy - physiopathology - surgery |
6 |
|
platelet aggregation inhibitors - administration & dosage - adverse effects |
6 |
|
recurrence |
6 |
|
registries |
6 |
|
risk factors |
6 |
|
stroke/prevention |
6 |
|
aged |
5 |
|
aged, 80 and over |
5 |
|
cathodal tdcs |
5 |
|
implicit motor learning |
5 |
|
left dorsolateral prefrontal cortex |
5 |
|
verbal working memory |
5 |
|
c6 glioma |
4 |
|
cell movement - drug effects |
4 |
|
cerebellar hemorrhages |
4 |
|
combined modality therapy |
4 |
|
complexity control |
4 |
|
conscious motor processing |
4 |
|
continuous tracking task |
4 |
|
diffusion weighting |
4 |
|
implicit learning |
4 |
|
individual differences |
4 |
|
lactate |
4 |
|
laparoscopic training |
4 |
|
lipid |
4 |
|
long-term outcome |
4 |
|
magnetic resonance spectroscopy |
4 |
|
molecular size |
4 |
|
movement self-consciousness |
4 |
|
movement specific reinvestment |
4 |
|
osce |
4 |
|
spectral overlapping |
4 |
|
time-on-task effect |
4 |
|
tomography, x-ray computed |
4 |
|
traumatic brain injury |
4 |
|
abdominal |
3 |
|
adhesion |
3 |
|
angiography, digital subtraction |
3 |
|
antigens, differentiation - genetics - metabolism |
3 |
|
antineoplastic agents, alkylating - adverse effects - therapeutic use |
3 |
|
apoptosis |
3 |
|
astrocytoma |
3 |
|
breast neoplasms - pathology |
3 |
|
cancer resistance |
3 |
|
carotid artery, internal - radiography |
3 |
|
cell death |
3 |
|
cell structure |
3 |
|
cell survival |
3 |
|
cerebral angiography |
3 |
|
cerebrovascular circulation |
3 |
|
chronic disease |
3 |
|
curriculum |
3 |
|
debridement |
3 |
|
debridement - adverse effects - methods |
3 |
|
diabetic foot - therapy |
3 |
|
diptera |
3 |
|
education, medical, undergraduate |
3 |
|
equipment design |
3 |
|
fluorodeoxyglucose f18 - diagnostic use |
3 |
|
gene expression regulation, neoplastic |
3 |
|
genes, tumor suppressor |
3 |
|
glioma - genetics - metabolism - pathology |
3 |
|
health facility administrators |
3 |
|
infarction, middle cerebral artery - etiology - physiopathology - radiography - surgery |
3 |
|
intracranial arteriosclerosis - complications |
3 |
|
larva |
3 |
|
leukemia, myeloid - chemically induced - genetics - radionuclide imaging |
3 |
|
leukemia, myelomonocytic, acute - pathology |
3 |
|
malignancy |
3 |
|
medical errors - prevention and control |
3 |
|
melanoma |
3 |
|
melanoma - diagnosis - secondary - surgery |
3 |
|
melphalan - adverse effects - therapeutic use |
3 |
|
meningeal neoplasms - chemically induced - genetics - radionuclide imaging |
3 |
|
metastasis |
3 |
|
micrornas - biosynthesis - genetics |
3 |
|
middle cerebral artery - radiography |
3 |
|
neoplasm recurrence, local - pathology - surgery |
3 |
|
neoplasms, second primary - chemically induced - genetics - radionuclide imaging |
3 |
|
pituitary |
3 |
|
pituitary neoplasms - diagnosis - secondary - surgery |
3 |
|
postoperative |
3 |
|
prevention |
3 |
|
radiography, interventional |
3 |
|
radiosurgery |
3 |
|
reduction |
3 |
|
retrospective studies |
3 |
|
safety management |
3 |
|
skin neoplasms - pathology - surgery |
3 |
|
stroke |
3 |
|
thrombectomy - instrumentation - methods |
3 |
|
thrombocytosis - complications - drug therapy |
3 |
|
tomography, emission-computed |
3 |
|
transsphenoidal approach |
3 |
|
wound healing |
3 |
|
wounds and injuries |
3 |
|
adenoma - pathology |
2 |
|
adolescent |
2 |
|
adrenal cortex hormones - therapeutic use |
2 |
|
animals |
2 |
|
antineoplastic agents, alkylating - pharmacology |
2 |
|
apparent diffusion coefficient |
2 |
|
attitude of health personnel |
2 |
|
attitudes |
2 |
|
blood-brain barrier |
2 |
|
body water |
2 |
|
brain - drug effects - pathology - physiopathology - surgery |
2 |
|
brain - wounds and injuries - china - hong kong. |
2 |
|
brain injuries - drug therapy - pathology - surgery - therapy |
2 |
|
brain neoplasms - blood supply - metabolism - pathology - secondary |
2 |
|
brain neoplasms - diagnosis - physiopathology |
2 |
|
brain neoplasms - drug therapy - genetics - therapy |
2 |
|
brain neoplasms - genetics - pathology |
2 |
|
brain tumor |
2 |
|
brain tumour |
2 |
|
capillary permeability |
2 |
|
carcinoma - blood supply - metabolism - pathology - secondary |
2 |
|
cell line, tumor |
2 |
|
cell survival - drug effects |
2 |
|
cell transformation, neoplastic - pathology - radiation effects |
2 |
|
central nervous system |
2 |
|
central pattern generator |
2 |
|
cerebral contusion |
2 |
|
cerebrospinal fluid |
2 |
|
chemoresistance |
2 |
|
child |
2 |
|
child, preschool |
2 |
|
chloride channels - physiology |
2 |
|
chlorotoxin |
2 |
|
clonal evolution |
2 |
|
complications |
2 |
|
copy number variation |
2 |
|
cortical resection model |
2 |
|
cranial fossa, posterior - surgery |
2 |
|
cranial irradiation - adverse effects |
2 |
|
craniotomy |
2 |
|
dacarbazine - analogs and derivatives - pharmacology |
2 |
|
diffusion |
2 |
|
diffusion magnetic resonance imaging - methods |
2 |
|
diffusion-weighted imaging |
2 |
|
disease progression |
2 |
|
dominance, cerebral - physiology |
2 |
|
dynamic contrast-enhanced mri |
2 |
|
education |
2 |
|
encephalocele |
2 |
|
endoscopy |
2 |
|
epigenetics |
2 |
|
epilepsy |
2 |
|
ethics, medical |
2 |
|
extracellular matrix - pathology |
2 |
|
fatal outcome |
2 |
|
genetic therapy |
2 |
|
glioblastoma |
2 |
|
glioblastoma - blood supply - metabolism - pathology |
2 |
|
glioblastoma - drug therapy - genetics - therapy |
2 |
|
glioma |
2 |
|
glioma - blood supply - metabolism - pathology |
2 |
|
glioma - genetics - pathology |
2 |
|
glioma cells |
2 |
|
growing fracture |
2 |
|
haemangiopericytoma |
2 |
|
head injury |
2 |
|
health knowledge, attitudes, practice |
2 |
|
hemangioma, cavernous - diagnosis - physiopathology |
2 |
|
hemangiopericytoma - pathology - radiotherapy - surgery |
2 |
|
hong kong |
2 |
|
immunohistochemistry |
2 |
|
infant |
2 |
|
inflammation |
2 |
|
inflammation - immunology |
2 |
|
informed consent |
2 |
|
interstitial loss of heterozygosity |
2 |
|
invasion |
2 |
|
ischemia - pathology |
2 |
|
large vessels occlusion |
2 |
|
lithium |
2 |
|
lncrna profiling |
2 |
|
lymphoma, b-cell - pathology |
2 |
|
lymphoma, large b-cell, diffuse - pathology |
2 |
|
magnetic resonance imaging |
2 |
|
matrix metalloproteinase 2 - physiology |
2 |
|
medical |
2 |
|
medical education |
2 |
|
medical errors |
2 |
|
medical students |
2 |
|
meningeal neoplasms - blood supply - metabolism - pathology |
2 |
|
meningeal neoplasms - pathology - radiotherapy - surgery |
2 |
|
meningioma - blood supply - metabolism - pathology |
2 |
|
mesencephalon - physiopathology |
2 |
|
microrna |
2 |
|
micrornas - antagonists and inhibitors - biosynthesis - genetics |
2 |
|
mononuclear cells |
2 |
|
multiple chloride channels |
2 |
|
nanofiber scaffold |
2 |
|
nanostructures - chemistry |
2 |
|
neoplasms, radiation-induced - pathology |
2 |
|
neuroglia - drug effects - immunology |
2 |
|
oligodendroglioma |
2 |
|
oligonucleotides, antisense - administration and dosage - genetics |
2 |
|
patient participation |
2 |
|
patient safety |
2 |
|
peptides - pharmacology - therapeutic use |
2 |
|
perfusion |
2 |
|
permeability |
2 |
|
pituitary apoplexy - etiology |
2 |
|
pituitary neoplasms - pathology |
2 |
|
precancer mutations |
2 |
|
radiotherapy, adjuvant |
2 |
|
rats |
2 |
|
rats, sprague-dawley |
2 |
|
reconstruction |
2 |
|
red nucleus - physiopathology |
2 |
|
regeneration - drug effects |
2 |
|
reoperation |
2 |
|
rescue |
2 |
|
rhabdomyosarcoma |
2 |
|
rhabdomyosarcoma - pathology |
2 |
|
sapns |
2 |
|
self-assembling peptide nanofiber scaffold |
2 |
|
single-nucleotide variation |
2 |
|
skull base |
2 |
|
spinal cord injury (sci) |
2 |
|
students |
2 |
|
students, medical |
2 |
|
students, medical - psychology |
2 |
|
surgical brain injury |
2 |
|
surgical embolectomy |
2 |
|
teaching - ethics |
2 |
|
temozolomide |
2 |
|
tissue scaffolds - chemistry |
2 |
|
tranexamic acid |
2 |
|
transfection |
2 |
|
transformation |
2 |
|
traumatic subarachnoid hemorrhage |
2 |
|
tremor - etiology - physiopathology |
2 |
|
tumor markers, biological - genetics |
2 |
|
tumor microenvironment |
2 |
|
tunel |
2 |
|
umbilical cord blood |
2 |
|
undergraduate |
2 |
|
young adult |
2 |
|
abducens nerve paralysis |
1 |
|
actin cytoskeleton |
1 |
|
acupuncture |
1 |
|
acute subdural haematoma |
1 |
|
adducin |
1 |
|
adenoma - secretion - surgery |
1 |
|
angiogenesis inhibitors - therapeutic use |
1 |
|
angiography |
1 |
|
antibodies, monoclonal, humanized - therapeutic use |
1 |
|
antineoplastic combined chemotherapy protocols |
1 |
|
antisepsis |
1 |
|
arachnoid cyst |
1 |
|
arachnoid cysts - complications - pathology |
1 |
|
autophagy |
1 |
|
autopsy |
1 |
|
autosomal dominant polycystic kidney disease |
1 |
|
brain diseases |
1 |
|
brain injury |
1 |
|
brain neoplasms |
1 |
|
brain neoplasms - drug therapy - mortality |
1 |
|
brain neoplasms - pathology - surgery |
1 |
|
burr hole craniostomy |
1 |
|
carcinoma - radiotherapy |
1 |
|
carotid artery diseases |
1 |
|
carotid stenosis - etiology - surgery |
1 |
|
cavernous sinus |
1 |
|
cell-matrix interaction |
1 |
|
cerebral hemorrhage |
1 |
|
cerebral revascularization |
1 |
|
cerebrospinal fluid leakage |
1 |
|
china |
1 |
|
chinese medicine |
1 |
|
chlorhexidine |
1 |
|
chondroblastoma - diagnosis - pathology - surgery |
1 |
|
chondromyxoid fibroma |
1 |
|
chronic subdural haematoma |
1 |
|
complication |
1 |
|
confusion - etiology |
1 |
|
dexamethasone |
1 |
|
dura mater |
1 |
|
education, premedical |
1 |
|
electron microscopy |
1 |
|
endoscopic surgical procedure |
1 |
|
endoscopy, gastrointestinal - adverse effects |
1 |
|
endovascular therapy |
1 |
|
epilepsy/surgeryepilepsy, temporal lobe |
1 |
|
fistula - etiology |
1 |
|
frontal sinus |
1 |
|
functional outcome |
1 |
|
functional survival |
1 |
|
gbm |
1 |
|
giant cell arteritis - complications |
1 |
|
glioblastoma - drug therapy |
1 |
|
glioblastoma multiforme |
1 |
|
glioma - drug therapy - mortality |
1 |
|
gliosarcoma - pathology - surgery |
1 |
|
granulomatous disease, chronic - complications |
1 |
|
graves disease - complications |
1 |
|
hand-washing |
1 |
|
health planning |
1 |
|
hematoma, epidural, cranial - etiology |
1 |
|
hematoma, subdural, chronic - complications - pathology |
1 |
|
herbal medicine |
1 |
|
histiocytoma, benign fibrous - complications |
1 |
|
hong kong - epidemiology |
1 |
|
human growth hormone - secretion |
1 |
|
humanities |
1 |
|
hydrocephalus - epidemiology - surgery |
1 |
|
hydrocortisone - blood |
1 |
|
hydronephrosis |
1 |
|
hypophysectomy |
1 |
|
hypophysis disease |
1 |
|
hypothyroidism - complications |
1 |
|
iciss |
1 |
|
infant, newborn |
1 |
|
inferior vena cava |
1 |
|
inflammation - pathology - surgery |
1 |
|
injury |
1 |
|
injury severity score |
1 |
|
internal carotid artery |
1 |
|
international cooperation |
1 |
|
intracranial aneurysm - radiography - surgery |
1 |
|
intracranial hypotension |
1 |
|
iodine-povidone |
1 |
|
iss |
1 |
|
laparotomy |
1 |
|
local |
1 |
|
magnetic resonance imaging - methods |
1 |
|
medical consultation -- study and teaching. |
1 |
|
medical sciences |
1 |
|
meningeal neoplasms - complications |
1 |
|
microscopy, electron |
1 |
|
moyamoya disease - radiography - surgery |
1 |
|
n-duopropenide |
1 |
|
nasal cavity |
1 |
|
nasopharyngeal neoplasms - complications - radiotherapy |
1 |
|
nasopharyngeal neoplasms - radiotherapy |
1 |
|
necrosis |
1 |
|
neoplasm recurrence |
1 |
|
neoplasms, radiation-induced - complications |
1 |
|
neoplasms, radiation-induced - surgery |
1 |
|
neoplasms, second primary - complications |
1 |
|
nervous system diseases - etiology - psychology - surgery |
1 |
|
neuroprotection |
1 |
|
neurorehabilitation |
1 |
|
neurosurgery |
1 |
|
neurosurgical procedures |
1 |
|
outcome |
1 |
|
pedicled flap |
1 |
|
peritumoral edema |
1 |
|
physician and patient -- study and teaching. |
1 |
|
pituitary adenoma |
1 |
|
pituitary diseases - diagnosis - surgery - therapy |
1 |
|
pituitary enlargement |
1 |
|
pituitary gland - metabolism - pathology - surgery |
1 |
|
pituitary neoplasms - complications |
1 |
|
pituitary neoplasms - secretion - surgery |
1 |
|
pneumocephalus - etiology - surgery |
1 |
|
polycystic kidney, autosomal dominant - complications - pathology |
1 |
|
postoperative complications |
1 |
|
prevalence |
1 |
|
progesterone |
1 |
|
prolactinoma - complications |
1 |
|
prosthesis-related infections - epidemiology |
1 |
|
pseudo-aneurysm |
1 |
|
pseudocyst |
1 |
|
radiotherapy - adverse effects |
1 |
|
receiver operator characteristic curve |
1 |
|
registries - statistics & numerical data |
1 |
|
registries - statistics and numerical data |
1 |
|
risk assessment |
1 |
|
risk factor |
1 |
|
rutin |
1 |
|
severe head injury |
1 |
|
skull neoplasms - diagnosis - pathology - surgery |
1 |
|
sphenoid bone |
1 |
|
srr |
1 |
|
stent |
1 |
|
stents |
1 |
|
steroids - therapeutic use |
1 |
|
subdural haematoma |
1 |
|
surgical approach |
1 |
|
survival |
1 |
|
system |
1 |
|
temporal lobe - pathology - surgery |
1 |
|
temporal lobe/surgery |
1 |
|
thinking |
1 |
|
tomography, spiral computed |
1 |
|
tomography, x-ray computed - methods |
1 |
|
trans-sphenoidal surgery |
1 |
|
transsphenoidal |
1 |
|
trauma |
1 |
|
trauma centers - organization and administration |
1 |
|
trauma centers - statistics & numerical data |
1 |
|
trauma scoring |
1 |
|
trauma severity indices |
1 |
|
trauma system |
1 |
|
triss |
1 |
|
ultrasonography |
1 |
|
vascular endothelial growth factor |
1 |
|
ventriculo-peritoneal shunt |
1 |
|
ventriculoperitoneal shunt - utilization |
1 |
|
ventriculostomy catheter |
1 |
|
ventriculostomy-related infection |
1 |
|
wounds and injuries - mortality - pathology |
1 |
|
wounds, nonpenetrating - diagnosis - epidemiology - therapy |
1 |
